← All trials
NCT04494321
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 19, 2017
- Primary completion
- Nov 17, 2017
- Completion date
- Nov 17, 2017
- First posted
- Jul 31, 2020
- Last posted
- Jul 31, 2020
- Enrollment
- 99
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Intech Biopharm Ltd.Lead sponsor
- Mackay Medical CollegeOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.